Firm News

Strategic Partners: The Power of Our Process

Since the early 1990s, the secondary private equity market has gone from a $150M market to a $60B market. As this market continues to grow, it’s critical to have a competitive edge. For Blackstone’s Strategic Partners, our advantage is our scale. In 2017, we closed 149 deals, across 1,200 interests and 859 funds. And each opportunity provides more data, fresh insights and a smarter approach on how to invest. Our team’s willingness to go deeper, move swiftly on complex opportunities and continually refine our approach makes us better investors. This advantage will be critical as the market continues to mature and evolve.

Nothing in this video or blog constitutes an offer to sell, or a solicitation of an offer to buy, any security or instrument in or to participate in any trading strategy with any Blackstone fund or other investment vehicle. An investment in Blackstone’s funds should be considered a speculative investment that entails substantial risks including, but not limited to, loss of all or a significant portion of the investment due to leveraging, short-selling, or other speculative practices, lack of liquidity and volatility of returns. Past performance is not indicative of future results and there can be no assurance that any Blackstone fund will be raised or that, if raised, it will achieve its objectives or avoid substantial losses. Opinions expressed reflect the current opinions of Blackstone as of the date appearing in this presentation only and are based on Blackstone’s opinions of the current market environment, which is subject to change. Statements contained in this video and blog post that are not facts, including statements regarding trends, market conditions and the expertise or experience of Blackstone, are based on current expectations, estimates, projections, opinions, and/or beliefs of Blackstone. Such statements are not facts and involve known and unknown risks, uncertainties, and other factors. The forgoing information has not been provided in a fiduciary capacity under ERISA, and it is not intended to be, and should not be considered as, research or impartial investment advice.